Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Mendelics | RCV002246255 | SCV002519324 | uncertain significance | not specified | 2022-05-04 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002491868 | SCV002789293 | uncertain significance | Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency | 2021-12-10 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003546686 | SCV004270494 | likely benign | not provided | 2023-08-10 | criteria provided, single submitter | clinical testing | |
University of Washington Center for Mendelian Genomics, |
RCV001261738 | SCV001439054 | likely pathogenic | Moyamoya angiopathy with developmental delay | no assertion criteria provided | research | ||
Prevention |
RCV004548111 | SCV004762880 | likely benign | SETD5-related disorder | 2023-11-20 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |